249 filings
Page 5 of 13
8-K
2k3pqp0zrun9n
14 Nov 17
Molecular Templates, Inc. Reports Third Quarter 2017 Financial Results
12:00am
8-K
x19fak20qfeu4v
14 Nov 17
Molecular Templates Strengthens Management Team with Appointment of
12:00am
8-K
hlv2x r0hfnv27wxklr
25 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K/A
20464uzz hc
17 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
i0bkcjyyteg3
13 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
t9qxp4lc45665yrr6u12
7 Aug 17
Molecular Templates Completes Merger with Threshold Pharmaceuticals and Private Placements
12:00am
8-K
ekahww yang2
1 Aug 17
Threshold Pharmaceuticals Announces Results of Annual Meeting of Stockholders
12:00am
8-K
msxsjnf6 457eg42rr
20 Jul 17
Other Events
12:00am
8-K
i9ocwxevcz5h
22 Jun 17
Completion of Acquisition or Disposition of Assets
12:00am
8-K
00jqvz9kl
2 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
7i83w 3fi4
15 May 17
Threshold Pharmaceuticals Reports First Quarter Financial Results
12:00am
8-K
6o6vp3oy6dp1 ymh44s
30 Mar 17
Regulation FD Disclosure
12:00am
8-K
mp8g9v
29 Mar 17
Regulation FD Disclosure
12:00am
8-K
xbjiv g9nl
27 Mar 17
Threshold Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
dsg5kvm
17 Mar 17
Threshold Pharmaceuticals and Molecular Templates Agree to Combine
12:00am
8-K
9hb7l5226
15 Nov 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
1hf8xk4xiwbpjyt7o
7 Nov 16
Threshold Pharmaceuticals Reports Third Quarter Financial Results
12:00am
8-K
f453ag2gx6iw16295
18 Oct 16
Departure of Directors or Certain Officers
12:00am
8-K
ja1o02ot
30 Sep 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
5bkvxj13b
29 Sep 16
Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program and its Plans to Focus on Evofosfamide and Earlier-Stage Opportunities
12:00am